Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with bacillus calmette-guérin: Results of a retrospective multicenter study of 2451 patients

Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Kathy Vander Eeckt, Vincenzo Serretta, Stéphane Larré, Savino Di Stasi, Bas Van Rhijn, Alfred J. Witjes, Anne J. Grotenhuis, Lambertus A. Kiemeney, Renzo Colombo, Alberto Briganti, Marek Babjuk, Per Uno Malmström, Marco Oderda, Jacques Irani, Nuria Malats, Jack BanielRoy Mano, Tommaso Cai, Eugene K. Cha, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Martin Spahn, Robert Johansson, Bruno Frea, Viktor Soukup, Evanguelos Xylinas, Guido Dalbagni, R. Jeffrey Karnes, Shahrokh F. Shariat, Joan Palou

Research output: Contribution to journal › Article › peer-review

139 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with bacillus calmette-guérin: Results of a retrospective multicenter study of 2451 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences